Stifel Nicolaus Downgrades Avanos Medical to Hold, Lowers Price Target to $35

Stifel Nicolaus downgrades Avanos Medical (NYSE:AVNS) from Buy to Hold and lowers the price target from $45 to $35.

Benzinga · 11/07/2019 11:36

Stifel Nicolaus downgrades Avanos Medical (NYSE:AVNS) from Buy to Hold and lowers the price target from $45 to $35.